Summit Global Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Summit Global Investments's IRMD Position: Q2 2026 in Review
Summit Global Investments reduced its iRadimed (IRMD) stake by 52% in Q2 2026, selling an estimated $361K and leaving 3,702 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #412.
Summit Global Investments first reported a position in IRMD in Q1 2020 and has held it in 18 quarters since. The position peaked at $737K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Summit Global Investments held 3,702 shares of iRadimed worth $354K as of Q2 2026.
- Summit Global Investments sold 3,959 iRadimed shares in Q2 2026, an estimated $361K.
- iRadimed made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #412 holding.
- Summit Global Investments first reported a position in iRadimed in Q1 2020 and has held it in 18 quarters since.
- Summit Global Investments's iRadimed position peaked at $737K in Q1 2026.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.